Key result
Calcium antagonists like diltiazem undergo review for efficacy and safety across major cardiovascular conditions.
Why the study?
What is the role, efficacy, and safety of calcium antagonists, specifically diltiazem, in the treatment of cardiovascular disease?
What is the role, efficacy, and safety of calcium antagonists, specifically diltiazem, in the treatment of cardiovascular disease?
This review summarizes the therapeutic role, nephroprotective effects, and safety profile of diltiazem and other calcium antagonists in managing various cardiovascular conditions.
Offers guidance on diltiazem use in CVD; leaves open need for updated comparative trials.
The article deals with the use of calcium antagonists (CA) with a focus on diltiazem for the treatment of hypertension, angina pectoris, and cardiac arrhythmias, for secondary prevention of coronary heart disease, to evaluate their cardiac, angiography, nephroprotective effect, the ability to prevent the development of left ventricular hypertrophy. The problems of tolerability and safety of CA in short and prolonged action.
No takes yet. Share an insight, caveat, or question.
Барышникова et al. (2015) conducted a review in Cardiovascular disease (hypertension, angina pectoris, cardiac arrhythmias, coronary heart disease). Calcium antagonists (diltiazem) was evaluated. Calcium antagonists, particularly diltiazem, are reviewed for their efficacy, safety, and tolerability in treating hypertension, angina, arrhythmias, and coronary heart disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: